Checked.be
Active
BE 0779.517.536Private limited company
C. CUV Management
Rue des Canadiens(SG) 17 ·7330 Saint-Ghislain, Belgium· 4 yrs active
Sector: Physiotherapy
(86951)
Conclusion
C. CUV Management has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98k and a net result of €4k. Equity is growing by ~21.7% per year across the filed fiscal years. Its solvency ranks better than 41% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €98k |
| Net result | €4k |
| Better than sector | 41% |
| Active | 4 yrs |
Financial profile
69
/ 100
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Health
86
Profitability
18
Solvency
96
Growth
52
Stability
94
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
86
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€8k
estimate, not credit advice
Score history
61
2022
100
2023
93
2024
86
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 6.18 (≥ 1.5)
+10
Quick ratio
Quick ratio 6.01 (≥ 1.0)
+5
Leverage
Debt/equity 0.88 (< 1.0)
+10
Profitability
ROE 4%
+3
Interest coverage
Interest coverage 3.6× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 30-08-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
At this pace, net result would indicatively turn negative around fiscal year 2026, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 53.1% | 63.4% | |
| Net result | €4k | €62k | |
| Equity | €98k | €132k | |
| Gross operating margin | €36k | €116k | |
| Total assets | €184k | €286k |
€35k
-17.7%
22-25
€4k
-83.5%
22-25
€19k
-47.2%
22-25
€184k
-4.3%
22-25
€98k
+0.2%
22-25
€121k
+24.7%
22-25
€10k
+61.8%
22-25
€86k
-8.0%
22-25
€23k
-44.2%
22-25
€61k
+45.4%
22-25
6.18
+86.2%
22-25
6.01
+81.3%
22-25
53.1%
+4.6%
22-25
0.88
-8.2%
22-25
3.7%
-83.5%
22-25
2.0%
-82.8%
22-25
3.56
-80.8%
22-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €35k | €42k | €49k | €39k |
| Net profit | €4k | €22k | €33k | €29k |
| Cash flow | €19k | €37k | €44k | €34k |
| Staff costs | - | - | - | - |
| Income taxes | €10k | €6k | €8k | €6k |
| Dividends | - | - | - | - |
| Total assets | €184k | €192k | €116k | €93k |
| Equity | €98k | €98k | €78k | €41k |
| Debt | €86k | €93k | €35k | €49k |
| of which ≤ 1y | €23k | €42k | €29k | €49k |
| of which > 1y | €61k | €42k | - | - |
| Working capital | €121k | €97k | €32k | €-3k |
| Employees (FTE) | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 6.18 | 3.32 | 2.10 | 0.95 |
| Quick ratio | 6.01 | 3.32 | 2.10 | 0.95 |
| Working capital ratio | 65.8% | 50.5% | 27.3% | -2.8% |
| Solvency | 53.1% | 50.7% | 67.6% | 44.4% |
| Debt / equity | 0.88 | 0.96 | 0.45 | 1.19 |
| Long-term debt ratio | 0.62 | 0.43 | - | - |
| Interest coverage | 3.56 | 18.56 | 265.65 | 1812.72 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 2.0% | 11.4% | 28.3% | 31.7% |
| ROE | 3.7% | 22.4% | 41.9% | 71.4% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €184k | €192k | €116k | €93k |
| Fixed assets | 21/28 | €40k | €53k | €55k | €47k |
| Intangible fixed assets | 21 | €30k | €44k | €51k | €47k |
| Tangible fixed assets | 22/27 | €10k | €9k | €5k | - |
| Current assets | 29/58 | €144k | €139k | €60k | €46k |
| Stocks & contracts in progress | 3 | €4k | - | - | - |
| Amounts receivable within one year | 40/41 | €21k | €122k | €53k | €44k |
| Cash & bank | 54/58 | €8k | €16k | €7k | €2k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €184k | €192k | €116k | €93k |
| Equity | 10/15 | €98k | €98k | €78k | €41k |
| Contributions / capital | 10/11 | €1k | €1k | €1k | €1k |
| Reserves | 13 | €88k | €84k | €62k | €29k |
| Provisions & deferred taxes | 16 | €585 | €1k | €2k | €3k |
| Amounts payable | 17/49 | €86k | €93k | €35k | €49k |
| Amounts payable after one year | 17 | €61k | €42k | - | - |
| Amounts payable within one year | 42/48 | €23k | €42k | €29k | €49k |
| Trade debts payable within one year | 44 | €3k | €34k | €14k | €25k |
| Income statement | |||||
| Gross operating margin | 9900 | €36k | €42k | €50k | €40k |
| Operating result | 9901 | €19k | €27k | €38k | €34k |
| Financial income | 75 | €4k | €3k | €3k | €1k |
| Financial charges | 65 | €10k | €2k | €185 | €21 |
| Result before taxes | 9903 | €13k | €27k | €41k | €35k |
| Income taxes | 67/77 | €10k | €6k | €8k | €6k |
| Net result for the period | 9904 | €4k | €22k | €33k | €29k |
| Result to be appropriated | 9905 | €4k | €22k | €33k | €29k |
Legal Structure
| NACE primary | Physiotherapy(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 30-12-2021 |
| Status | Active |
| Postal code | 7330 |
Establishment units
C. CUV Management
since 20212.331.734.795
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53070B0588/00N006 | Wallonia | 916 m² | 1 · 138 m² | 8.8 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 30 days late
2025
31-12
Financial
Weakest financial yearnet €4k ▼83.5%
Net result drops to €4k, the lowest in the series.
09-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 70 days late
2024
10-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2022net €33k ▲11.2%
Operating result €38k, net result €33k, both a record.
31-12
Financial
Liquidity doublescurrent ratio 2.10
Current ratio from 0.95 to 2.10; short-term debt falls from €49k to €29k.
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Human health activities86905Physiotherapy86951Business and other management consultancy70200Business consulting70220
Names & trade names
| Legal nameFR | C. CUV Management |
Similar companies
SD Kinemathe
BE 0728.936.093 · Mechelen
LM THERAPIE
BE 0842.198.441 · Frameries
BALASA
BE 0740.539.471 · Tielt
MOVE U
BE 0677.823.132 · Ravels
Mei Li De Ren
BE 0776.511.427 · Ranst